InvestorsHub Logo
Followers 7
Posts 450
Boards Moderated 0
Alias Born 03/06/2009

Re: diarch post# 43660

Monday, 11/17/2014 6:36:22 PM

Monday, November 17, 2014 6:36:22 PM

Post# of 329059
We have a 'tiny' company with a technology that can change the face of pain treatments, yet as always money and greed get in the way. So what do you think the motivation of the FDA director was to approve a drug her own health advisory counsel disapproved of? Who talked to her? What was she promised? The sad thing is this goes on all the time with the FDA, as they simply remain the tool of big pharma and big drug companies. Chronic pain is a $60B a year industry for the big boys, and now this pip squeak of a company comes along with this innovative solution. People are dying each and every day from the products/drugs these companies produce, and they simply don't care as the money rolls in each and every day. The pressure to crush, defer, delay this technology has to be enormous as companies stand to lose billions if this is approved and gets onto shelves in the U.S.
Overdue . . . they can delay and make excuses forever when the puppet masters are pulling the strings. jm2¢